Bergan, S., Brunet, M., Hesselink, D. A., Johnson-Davis, K. L., Kunicki, P. K., Lemaitre, F., . . . Langman, L. J. (2021). Personalized therapy for mycophenolate: Consensus report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring, 43(2), . https://doi.org/10.1097/FTD.0000000000000871
Chicago Style (17th ed.) CitationBergan, Stein, et al. "Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology." Therapeutic Drug Monitoring 43, no. 2 (2021). https://doi.org/10.1097/FTD.0000000000000871.
MLA (9th ed.) CitationBergan, Stein, et al. "Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology." Therapeutic Drug Monitoring, vol. 43, no. 2, 2021, https://doi.org/10.1097/FTD.0000000000000871.